Contineum Therapeutics, Inc. Ratios

Ratios Dec2023 Dec2024
Profitability
EBT Margin 46.34%
EBIT Margin 32.15%
EBITDA Margin 45.81%
Operating Margin 32.15%
Net Margin 45.44%
FCF Margin 37.87%
Efficiency
Assets Average 171.62M
Equity Average 65.06M
Invested Capital -67.94M198.07M
Leverage & Solvency
Interest Coverage Ratio 77.29
Equity Ratio -0.520.93
Times Interest Earned 77.29
Valuation
Enterprise Value -125.19M172.88M
Market Capitalization 377.64M
Return Ratios
Return on Sales 0.45%
Return on Capital Employed -0.31%
Return on Assets -0.25%
Return on Equity -0.65%